Interaction Details

There were no interactions found between Ibrutinib and 7-keto-dhea. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.


Still looking for more information about combining Ibrutinib and 7-keto-dhea? Ask Dr. Brian Staiger about it by contacting him directly.

7-keto-dhea Overview

7-keto-dhea 7-keto DHEA (7-oxo-dehydroepiandrosterone) is a metabolite of the hormone dehydroepiandrosterone (DHEA), which is produced by the adrenal glands. It is often used as a non-hormonal supplement to promote weight loss, improve muscle mass and increase metabolism. Some studies have suggested that 7-keto DHEA may aid weight loss by increasing the activity of thermogenic enzymes, which are responsible for burning fat. It is also believed to increase muscle mass by stimulating protein synthesis and reducing muscle breakdown. Additionally, 7-keto DHEA may have antioxidant properties that could help protect cells from damage caused by free radicals. Unlike DHEA, 7-keto DHEA does not convert to estrogen or testosterone and does not activate androgen receptors, thus, it is not considered to have the same risks as DHEA supplements. However, more research is needed to confirm the safety and effectiveness of 7-keto DHEA as a supplement.
See More Information Regarding 7-keto-dhea

Ibrutinib Overview

  • Ibrutinib is used:

    • to treat people with mantle cell lymphoma (MCL; a fast-growing cancer that begins in the cells of the immune system) who have already been treated with at least one other chemotherapy medication,

    • to treat people with chronic lymphocytic leukemia (CLL; a type of cancer that begins in the white blood cells) and small lymphocytic lymphoma (SLL; a type of cancer that begins mostly in the lymph nodes),

    • to treat people with Waldenstrom's macroglobulinemia (WM; a slow-growing cancer that begins in certain white blood cells in your bone marrow),

    • to treat people with marginal zone lymphoma (MZL; a slow growing cancer that begins in a type of white blood cells that normally fights infection) who have already been treated with a certain type of chemotherapy medication,

    • and to treat people with chronic graft vs host disease (cGVHD; a complication of hematopoietic stem-cell transplant [HSCT; a procedure that replaces diseased bone marrow with healthy bone marrow] that may start a while after the transplant and last for a long time) after being treated unsuccessfully with 1 or more medications.

  • Ibrutinib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps stop the spread of cancer cells.

See More Information Regarding Ibrutinib

7-keto-dhea - More Interactions

7-keto-dhea interacts with 0 drugs

Interaction Rating Key

These severity listings are for informational use only. Never start, stop or otherwise change your therapy before speaking with your provider.

Major The combined use of these agents is strongly discouraged as serious side effects or other negative outcomes could occur.
Moderate Use cautiously under the care of a healthcare professional or avoid this combination. A significant interaction or negative outcome could occur.
Minor Be aware that there is a chance of an interaction. Watch for warning signs of a potential interaction.
Unknown No interactions have been reported or no interaction data is currently available.

Return to the main herbal interaction checker page

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Drug descriptions are provided by MedlinePlus.

Ask A Pharmacist About Your Herbal Questions!

Dr. Brian Staiger, PharmD

In addition to being a clinical pharmacist specializing in pharmacotherapy, Dr. Brian Staiger is a registered herbalist through the American Herbalist Guild. He has combined his passion for pharmacy practice with the study of medical ethnobotany to improve patient care. Feel free to reach out about any of your herbal or medication questions!

Ask A Pharmacist